Five cases were performed at National University Hospital (NUH) and Changi General Hospital (CGH).

The Chocolate PTA design represents a breakthrough in PTA balloon catheters. The Chocolate PTA is used for the treatment of patients with vascular disease in their legs, known as PAD. It was designed to provide predictable, uniform, less traumatic dilatation of peripheral vasculature.

The Chocolate PTA has demonstrated a very low rate of dissections and bail-out stenting in clinical studies in the US.

QT Vascular’s product pipeline includes a drug-coated chocolate balloon. It combines the acute benefits of the Chocolate PTA with paclitaxel-based coating, an anti-proliferative drug that has been shown to be efficacious in the prevention of re-narrowing of the artery over time.

QT Vascular CEO Dr Eitan Konstantino noted that the cases performed at these prestigious institutions mark a key milestone in the company’s journey to bring improved PAD treatment options to patients

"We are very excited to treat patients in Singapore, our home base," Dr Konstantino added.